November 13, 2023 - Monday

[WORLD] Israeli tank stationed outside Gaza hospital as medics plead for fuel to save patients, including newborn babies.

Israeli forces have reached the gates of Gaza City's main hospital, where medics say patients, including newborn babies, are dying due to a lack of fuel. The hospital's operating rooms are out of service due to a lack of electricity, leaving staff unable to perform surgeries. The situation highlights the urgent need for fuel and medical supplies in Gaza. Meanwhile, there are concerns that the war could spread beyond Gaza, with clashes on Israel's northern border and the United States launching airstrikes in neighboring Syria.

No sources available.

[NATION] Republican Tim Scott announced the suspension of his presidential campaign during an interview on Fox News.

Tim Scott, a Republican senator from South Carolina, revealed on "Sunday Night in America with Trey Gowdy" that he will be suspending his 2024 presidential campaign. Scott cited the voters' feedback, stating that they have made it clear that it is not the right time for him to run. He also mentioned that he has no plans to endorse another candidate in the race. Scott's decision comes after canceling his Iowa swing due to illness, though his campaign remained positive about his chances for the GOP nomination.

No sources available.

[BUSINESS] Verve Therapeutics' one-time gene-editing treatment significantly lowers LDL cholesterol levels in patients at high risk of early heart attack due to inherited high cholesterol.

Verve Therapeutics has reported that their gene-editing therapy, VERVE-101, has successfully lowered low-density lipoprotein cholesterol (LDL) levels in patients with inherited high cholesterol in a first-in-human study. The treatment, which uses CRISPR-based gene editing technology, permanently turns off the PCSK9 gene in the liver, resulting in reduced LDL cholesterol levels. If proven to be safe and effective in further studies, this one-time therapy could provide long-term benefits in managing high cholesterol levels and potentially reduce the risk of heart attack.

No sources available.

[TECHNOLOGY] The Humane Ai Pin, an AI wearable aiming to replace smartphones, lacks a screen and shows flaws in its performance, signaling potential failure.

The Humane Ai Pin, developed by ex-Apple employees, has finally been unveiled as a screenless AI wearable. It aims to replace smartphones but lacks a screen, making tasks more difficult. Critics argue that the device's flaws, showcased in a recent video, suggest it may be a failure. The AI provides incorrect answers and offers no method to verify accuracy. Without significant improvements, the Ai Pin may struggle to gain traction and compete with traditional smartphones.

No sources available.

[SPORTS] Penn State's loss to Michigan leaves their season feeling unsatisfying, as they are once again winless against top Big Ten teams.

Despite a successful 11-2 season last year, Penn State's current season will not be satisfying, as they can only achieve an 11-2 record with a victory in a New Year's Six bowl. In the recent game against Michigan, Penn State struggled offensively while containing their opponents, but ultimately fell short. The Jim Harbaugh-less Wolverines emphasized the running game, with offensive coordinator Sherrone Moore leading the team to victory and dedicating it to Harbaugh. Harbaugh has been suspended for sign-stealing allegations.

No sources available.

[SCIENCE] SpaceX successfully launched two O3b mPOWER communication satellites into medium Earth orbit, marking its 84th mission of 2023.

On its 84th mission of the year, SpaceX launched the SES O3b mPOWER communication satellites into medium Earth orbit. The Falcon 9 rocket carrying the satellites lifted off from Cape Canaveral Space Force Station in Florida. This launch is part of SpaceX's contract with SES to provide internet-providing satellites. The satellites will begin being deployed soon and will contribute to the SES O3b mPOWER constellation.

No sources available.

[HEALTH] Verve Therapeutics' one-time treatment powered by CRISPR base editing showed potential in reducing bad cholesterol levels in patients with inherited cardiovascular disease.

Verve Therapeutics presented preliminary study results showing that their one-time treatment, VERVE-101, powered by CRISPR base editing, resulted in reductions in LDL-C levels in patients with inherited cardiovascular disease. Three patients in the study showed reductions in bad cholesterol levels of 39%, 48%, and 55%, with the latter patient maintaining the decline for six months. The study results were presented at the American Heart Association conference and represent the first use of base editing to modify DNA letters in patients. Verve licensed the base-editing technology from Beam Therapeutics.

No sources available.

[ENTERTAINMENT] Travis Kelce departs Argentina after being seen kissing and holding hands with Taylor Swift during her Eras Tour concert.

Kansas City Chiefs' tight end Travis Kelce was spotted leaving Argentina after being seen engaging in PDA with singer Taylor Swift. Kelce flew to Argentina to attend one of Swift's Eras Tour concerts during the team's bye week. Photos captured the couple holding hands during dinner and kissing after the concert. Swift even changed the lyrics of her song "Karma" to mention Kelce during the performance. Kelce quickly returned to the US for football practice.

No sources available.